Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Brain atrophy in multiple sclerosis: therapeutic, cognitive and clinical impact.
A retrospective case series of pediatric spinal cord injury and disease in Victoria, Australia.
In vivo regulation of gene expression and Th17 differentiation by RORγt inverse agonists.
Polysialic acid modification of the synaptic cell adhesion molecule SynCAM 1 in human embryonic stem cell-derived oligodendrocyte precursor cells.
Comprehensive Review of Ocular Angiostrongyliasis with Special Reference to Optic Neuritis.
Cutting-edge of advanced MRI for demyelinating diseases.
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
Bilateral claw hand: An uncommon presentation of regional Guillain-Barré syndrome.
Use of altered informed consent in pragmatic clinical research.
Apoptosis of Oligodendrocytes during Early Development Delays Myelination and Impairs Subsequent Responses to Demyelination.
The Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells.
Translational utility of experimental autoimmune encephalomyelitis: recent developments.
Acute Disseminated Encephalomyelitis After Human Parechovirus Infection.
Multiple Sclerosis Associated Risk Factors: A Case-Control Study.
Protein kinase C gamma (PKCγ) as a novel marker to assess the functional status of the corticospinal tract in experimental autoimmune encephalomyelitis (EAE).
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Implication of matrix metalloproteinases in regulating neuronal disorder.
Aquaporin-4: A novel diagnostic biomarker for seronegative neuromyelitis optica.
Integrating p38α MAPK immune signals in nonimmune cells.
Measures of respiratory function correlate with fatigue in ambulatory persons with multiple sclerosis.
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.
Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid.
Predictors of executive complaints and executive deficits in multiple sclerosis.
Pages
« first
‹ previous
…
607
608
609
610
611
612
613
614
615
…
next ›
last »